Cargando…

SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura

Detalles Bibliográficos
Autores principales:	Shah, Hridaya, Kim, Ann, Sukumar, Senthil, Mazepa, Marshall, Kohli, Ruhail, Braunstein, Evan M., Brodsky, Robert A., Cataland, Spero, Chaturvedi, Shruti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Letter to Blood
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906888/ https://www.ncbi.nlm.nih.gov/pubmed/35259252 http://dx.doi.org/10.1182/blood.2022015545

Ejemplares similares

Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
por: Sukumar, Senthil, et al.
Publicado: (2021)

Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab
por: Sukumar, Senthil, et al.
Publicado: (2020)

Clinical relapse of immune‐mediated thrombotic thrombocytopenic purpura following COVID‐19 vaccination
por: Deucher, William, et al.
Publicado: (2022)

Novel therapies in thrombotic thrombocytopenic purpura
por: Masias, Camila, et al.
Publicado: (2017)

Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
por: Picod, Adrien, et al.
Publicado: (2022)

Health following recovery from immune thrombotic thrombocytopenic purpura: the patient’s perspective
por: Kelley, Rachel A., et al.
Publicado: (2022)

Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship
por: Selvakumar, Sruthi, et al.
Publicado: (2023)

Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)
por: Paulsen, Finn-Ole, et al.
Publicado: (2021)

Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission
por: Sukumar, Senthil, et al.
Publicado: (2022)

C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
por: Shah, Hridaya, et al.
Publicado: (2022)

COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria
por: Gerber, Gloria F., et al.
Publicado: (2021)

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)

Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study
por: Knoebl, Paul, et al.
Publicado: (2019)

Thrombotic Thrombocytopenic Purpura and Gemcitabine
por: Kasi, Pashtoon Murtaza
Publicado: (2011)

Dengue and Thrombotic Thrombocytopenic Purpura
por: Wiwanitkit, Viroj
Publicado: (2017)

Vaccination and Thrombotic Thrombocytopenic Purpura
por: Yavaşoğlu, İrfan
Publicado: (2020)

Caplacizumab for thrombotic thrombocytopenic purpura
Publicado: (2020)

Hereditary Thrombotic Thrombocytopenic Purpura
por: Nusrat, Sanober, et al.
Publicado: (2023)

Cardiovascular Disease and Stroke in Immune TTP–Challenges and Opportunities
por: Sukumar, Senthil, et al.
Publicado: (2023)

Thrombotic Thrombocytopenic Purpura Associated with Pazopanib
por: Syed, Umer, et al.
Publicado: (2018)

Thrombotic Thrombocytopenic Purpura Associated with Dermatomyositis
por: Malik, Zohra R, et al.
Publicado: (2018)

Cardiac implications of thrombotic thrombocytopenic purpura
por: Wiernek, Szymon L, et al.
Publicado: (2018)

Ticagrelor-associated thrombotic thrombocytopenic purpura
por: Doğan, Ali, et al.
Publicado: (2017)

Valacyclovir-Induced Thrombotic Thrombocytopenic Purpura
por: Bukhari, Sumera, et al.
Publicado: (2020)

Thrombotic thrombocytopenic purpura secondary to Streptococcus
por: Morrin, M.J., et al.
Publicado: (2006)

Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura
por: Arıkan, Fatma, et al.
Publicado: (2020)

Caplacizumab for Acute Thrombotic Thrombocytopenic Purpura
por: Katsivalis, Katherine V., et al.
Publicado: (2021)

Daratumumab for immune thrombotic thrombocytopenic purpura
por: van den Berg, Jana, et al.
Publicado: (2022)

Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura
por: Ban, Byung H., et al.
Publicado: (2017)

Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report
por: Ge, Hangping, et al.
Publicado: (2022)

Concurrence of immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura: a case report and review of the literature
por: Lin, Hung-Chen, et al.
Publicado: (2023)

Thrombotic thrombocytopenic purpura associated with cerebral SLE.
por: McHenry, M., et al.
Publicado: (2003)

Moxifloxacin (Avelox) Induced Thrombotic Thrombocytopenic Purpura
por: Surana, Sikander P., et al.
Publicado: (2012)

Thrombotic thrombocytopenic purpura in the first trimester of pregnancy
por: Sikka, Pooja, et al.
Publicado: (2013)

Management of thrombotic thrombocytopenic purpura: current perspectives
por: Blombery, Piers, et al.
Publicado: (2014)

Opana(®) ER induced thrombotic thrombocytopenic purpura
por: Kotbi, Nabil, et al.
Publicado: (2015)

Recombinant thrombomodulin for secondary thrombotic thrombocytopenic purpura
por: Nakamura, Kensuke, et al.
Publicado: (2016)

Acute pancreatitis induced thrombotic thrombocytopenic purpura
por: Ali, Mohammed Arshad, et al.
Publicado: (2014)

Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura
por: Scully, Marie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0248b6qpmqcq2v68p1v9m9mrug